Company Filing History:

9 out of 9

Molecular Geriatrics Corporation

patents

8 out of 4,179

Abbott Laboratories Corporation

patents

1 out of 1

Molecualr Geriatrics Corporation

patent

Years Active: 1986-2007

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7173132 - Certain substituted 1-aryl-3-piperazine-1'-yl propanones (2007-02-06),

2. 6864062 - Purified antigen for Alzheimer's disease and methods of obtaining and using same (2005-03-08),

3. 6306857 - Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones (2001-10-23),

4. 6228878 - Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanones (2001-05-08),

5. 6214994 - Certain substituted 1-aryl-3-piperazin-1′-yl propanones (2001-04-10),

6. 6075026 - Certain substituted 1-aryl-3-piperazin-1'-yl propanones (2000-06-13),

7. 5968936 - Methods for treating or preventing Alzheimer's Disease using substituted (1999-10-19),

8. 5705501 - Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's (1998-01-06),

9. 5693804 - Substituted 1-aryl-3-piperazin-1'-yl propanones (1997-12-02),

10. 5658909 - Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat (1997-08-19),

11. 5559144 - Furyl and thienyl alkynyl-N-hydroxy urea derivatives (1996-09-24),

12. 5476873 - Acetylene derivatives having lipoxygenase inhibitory activity (1995-12-19),

13. 5389638 - Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake (1995-02-14),

14. 5326776 - Angiotensin II receptor antagonists (1994-07-05),

15. 5250548 - Angiotensin II receptor antagonists (1993-10-05),

Title: The Innovative Journey of Daniel Joseph Kerkman

Introduction:

Daniel Joseph Kerkman, a prolific inventor, has made significant contributions in the field of pharmaceuticals and Alzheimer's disease research. With a location in Lake Villa, IL (US), he has been the mind behind 18 patents and continues to drive advancements in the industry.

Latest Patents:

Among his latest patents is the development of "Certain substituted 1-aryl-3-piperazine-1'-yl propanones," a compound designed to address specific medical needs. Additionally, his work on "Purified antigen for Alzheimer's disease" showcases his commitment to enhancing diagnostic tools for this prevalent neurological condition.

Career Highlights:

Having worked at Molecular Geriatrics Corporation and Abbott Laboratories, Kerkman has demonstrated his expertise in pharmaceutical research and development. His innovative approach to problem-solving has led to groundbreaking solutions in the medical field.

Collaborations:

Throughout his career, Kerkman has collaborated with esteemed professionals such as John F DeBernardis and Raymond Paul Zinkowski. These collaborations have further enriched his projects and led to successful outcomes in the industry.

Conclusion:

In conclusion, Daniel Joseph Kerkman's dedication to innovation in pharmaceuticals and Alzheimer's disease research has solidified his position as a visionary inventor. His patents and collaborations stand as a testament to his profound impact on the field, paving the way for advancements that benefit society as a whole.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com